Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges

Dionisios Spyratos, Eleni Papadaki, Sofia Lampaki, Theodoros Kontakiotis Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece Abstract: Chronic obstructive pulmonary disease (COPD) and lung ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Spyratos D, Papadaki E, Lampaki S, Kontakiotis T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	lung cancer COPD coexistence risk factor therapy decisions Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/c4e5e5ca53924b9f9ac15b74495c7e74
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c4e5e5ca53924b9f9ac15b74495c7e74
record_format	dspace
spelling	oai:doaj.org-article:c4e5e5ca53924b9f9ac15b74495c7e742021-12-02T01:39:15ZChronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges1179-2728https://doaj.org/article/c4e5e5ca53924b9f9ac15b74495c7e742017-08-01T00:00:00Zhttps://www.dovepress.com/chronic-obstructive-pulmonary-disease-in-patients-with-lung-cancer-pre-peer-reviewed-article-LCTThttps://doaj.org/toc/1179-2728Dionisios Spyratos, Eleni Papadaki, Sofia Lampaki, Theodoros Kontakiotis Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece Abstract: Chronic obstructive pulmonary disease (COPD) and lung cancer share a common etiological factor (cigarette smoking) and usually coexist in everyday clinical practice. The prevalence of COPD among newly diagnosed patients with lung cancer sometimes exceeds 50%. COPD is an independent risk factor (2–4 times higher than non-COPD subjects) for lung cancer development.The presence of emphysema in addition to other factors (e.g., smoking history, age) could be incorporated into risk scores in order to define the most appropriate target group for lung cancer screening using low-dose computed tomography. Clinical management of patients with coexistence of COPD and lung cancer requires a multidisciplinary oncology board that includes a pulmonologist. Detailed evaluation (lung function tests, cardiopulmonary exercise test) and management (inhaled drugs, smoking cessation, pulmonary rehabilitation) of COPD should be taken into account for lung cancer treatment (surgical approach, radiotherapy). Keywords: lung cancer, COPD, coexistence, risk factor, therapy decisions Spyratos DPapadaki ELampaki SKontakiotis TDove Medical Pressarticlelung cancerCOPDcoexistencerisk factortherapy decisionsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENLung Cancer: Targets and Therapy, Vol Volume 8, Pp 101-107 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	lung cancer COPD coexistence risk factor therapy decisions Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	lung cancer COPD coexistence risk factor therapy decisions Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Spyratos D Papadaki E Lampaki S Kontakiotis T Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
description	Dionisios Spyratos, Eleni Papadaki, Sofia Lampaki, Theodoros Kontakiotis Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece Abstract: Chronic obstructive pulmonary disease (COPD) and lung cancer share a common etiological factor (cigarette smoking) and usually coexist in everyday clinical practice. The prevalence of COPD among newly diagnosed patients with lung cancer sometimes exceeds 50%. COPD is an independent risk factor (2–4 times higher than non-COPD subjects) for lung cancer development.The presence of emphysema in addition to other factors (e.g., smoking history, age) could be incorporated into risk scores in order to define the most appropriate target group for lung cancer screening using low-dose computed tomography. Clinical management of patients with coexistence of COPD and lung cancer requires a multidisciplinary oncology board that includes a pulmonologist. Detailed evaluation (lung function tests, cardiopulmonary exercise test) and management (inhaled drugs, smoking cessation, pulmonary rehabilitation) of COPD should be taken into account for lung cancer treatment (surgical approach, radiotherapy). Keywords: lung cancer, COPD, coexistence, risk factor, therapy decisions
format	article
author	Spyratos D Papadaki E Lampaki S Kontakiotis T
author_facet	Spyratos D Papadaki E Lampaki S Kontakiotis T
author_sort	Spyratos D
title	Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
title_short	Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
title_full	Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
title_fullStr	Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
title_full_unstemmed	Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
title_sort	chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/c4e5e5ca53924b9f9ac15b74495c7e74
work_keys_str_mv	AT spyratosd chronicobstructivepulmonarydiseaseinpatientswithlungcancerprevalenceimpactandmanagementchallenges AT papadakie chronicobstructivepulmonarydiseaseinpatientswithlungcancerprevalenceimpactandmanagementchallenges AT lampakis chronicobstructivepulmonarydiseaseinpatientswithlungcancerprevalenceimpactandmanagementchallenges AT kontakiotist chronicobstructivepulmonarydiseaseinpatientswithlungcancerprevalenceimpactandmanagementchallenges
_version_	1718402983239090176

Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges

Ejemplares similares